CLYM
Climb Bio, Inc.
Key Financials
Operating Income
$-67883000
↑ 17.2%
Net Income
$-59851000
↑ 19.0%
EPS (Diluted)
$-0.88
↑ 42.5%
Total Assets
$167.7M
↓ 22.8%
Cash & Equivalents
$35.7M
↓ 59.1%
Total Liabilities
$7.3M
↑ 37.0%
Shareholders' Equity
$160.5M
↓ 24.3%
Operating Cash Flow
$-54356000.00
↓ 249.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CLYM |
| Company Name | Climb Bio, Inc. |
| CIK | 1768446 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 1-866-857-2596 |